» Articles » PMID: 33916793

Diversity of Conopeptides and Conoenzymes from the Venom Duct of the Marine Cone Snail As Determined from Transcriptomic and Proteomic Analyses

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2021 Apr 30
PMID 33916793
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Marine cone snails are predatory gastropods characterized by a well-developed venom apparatus and highly evolved hunting strategies that utilize toxins to paralyze prey and defend against predators. The venom of each species of cone snail has a large number of pharmacologically active peptides known as conopeptides or conotoxins that are usually unique in each species. Nevertheless, venoms of only very few species have been characterized so far by transcriptomic approaches. In this study, we used transcriptome sequencing technologies and mass spectrometric methods to describe the diversity of venom components expressed by a worm-hunting species, . A total of 82 conotoxin sequences were retrieved from transcriptomic data that contain 54 validated conotoxin sequences clustered into 21 gene superfamilies including divergent gene family, 17 sequences clustered to 6 different conotoxin classes, and 11 conotoxins classified as unassigned gene family. Seven new conotoxin sequences showed unusual cysteine patterns. We were also able to identify 19 peptide sequences using mass spectrometry that completely overlapped with the conotoxin sequences obtained from transcriptome analysis. Importantly, herein we document the presence of 16 proteins that include five post-translational modifying enzymes obtained from transcriptomic data. Our results revealed diverse and novel conopeptides of an unexplored species that could be used extensively in biomedical research due to their therapeutic potentials.

Citing Articles

In Silico Conotoxin Studies: Progress and Prospects.

Li R, Hasan M, Wang D Molecules. 2025; 29(24.

PMID: 39770149 PMC: 11677113. DOI: 10.3390/molecules29246061.


Redox-Active Conopeptide Li520 Has Evolved to Catalyze Oxidative Folding of Conotoxins.

Dhannura S, Shekh S, Dhurjad P, Dolle A, Kakkat S, Vishwajyothi ACS Omega. 2024; 9(36):37596-37609.

PMID: 39281945 PMC: 11391441. DOI: 10.1021/acsomega.4c01028.


Stapling Cysteine[2,4] Disulfide Bond of α-Conotoxin LsIA and Its Potential in Target Delivery.

Sun X, Hu J, Ren M, Chang H, Zhangsun D, Zhang B Mar Drugs. 2024; 22(7).

PMID: 39057423 PMC: 11278161. DOI: 10.3390/md22070314.


Synthesis and Characterization of an Analgesic Potential Conotoxin Lv32.1.

Liu S, Li C, You S, Yan Q, Luo S, Fu Y Molecules. 2022; 27(23).

PMID: 36500709 PMC: 9741281. DOI: 10.3390/molecules27238617.


Structural and Functional Diversity of Animal Toxins Interacting With GPCRs.

Van Baelen A, Robin P, Kessler P, Maiga A, Gilles N, Servent D Front Mol Biosci. 2022; 9:811365.

PMID: 35198603 PMC: 8859281. DOI: 10.3389/fmolb.2022.811365.

References
1.
Peng C, Huang Y, Bian C, Li J, Liu J, Zhang K . The first Conus genome assembly reveals a primary genetic central dogma of conopeptides in C. betulinus. Cell Discov. 2021; 7(1):11. PMC: 7900195. DOI: 10.1038/s41421-021-00244-7. View

2.
Livett B, Gayler K, Khalil Z . Drugs from the sea: conopeptides as potential therapeutics. Curr Med Chem. 2004; 11(13):1715-23. DOI: 10.2174/0929867043364928. View

3.
Barghi N, Concepcion G, Olivera B, Lluisma A . Structural features of conopeptide genes inferred from partial sequences of the Conus tribblei genome. Mol Genet Genomics. 2015; 291(1):411-22. DOI: 10.1007/s00438-015-1119-2. View

4.
Jain R, Jayaseelan B, Alphonse C, Hossam Mahmoud A, Mohammed O, Ahmed Almunqedhi B . Mass spectrometric identification and sequencing of novel conotoxins from vermivorous cone snail (), and preliminary screening of its venom for biological activities and . Saudi J Biol Sci. 2021; 28(3):1582-1595. PMC: 7938137. DOI: 10.1016/j.sjbs.2020.12.032. View

5.
Giribaldi J, Ragnarsson L, Pujante T, Enjalbal C, Wilson D, Daly N . Synthesis, Pharmacological and Structural Characterization of Novel Conopressins from . Mar Drugs. 2020; 18(3). PMC: 7143535. DOI: 10.3390/md18030150. View